The Efficacy and Safety of Arbidol in Reducing the Frequency of AECOPD.

PHASE4CompletedINTERVENTIONAL

Enrollment

351

Participants

Timeline

Start Date

August 30, 2019

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2024

Conditions

COPD Patients

Interventions

DRUG

Arbidol

oral

DRUG

Placebos

controle

Trial Locations (1)

Shenjing Hospital, Shenyang

All Listed Sponsors

lead

Shengjing Hospital

OTHER

NCT03851991 - The Efficacy and Safety of Arbidol in Reducing the Frequency of AECOPD. | Biotech Hunter | Biotech Hunter